Everyone is talking about this FDA peptide update But almost no one is explaining it correctly. So let's break it down In 2023, many peptides were placed into Category 2 Frontiers Hydroxyurea mitigates diabetic kidney disease through mTOR S6K signaling pathway in STZ induced diabetic mice Renal Toxicity From Pemetrexed and Pembrolizumab in the Era of Combination Therapy in Patients With Metastatic Nonsquamous Cell NSCLC Journal of Thoracic Oncology Lithium Induced Renal Dysfunction: Pathophysiology and Clinical Implications Lithium Induced Renal Dysfunction: Pathophysiology and Clinical Implications Renal health and the environment: heavy metal nephrotoxicity Nefrologa